Fundraising Fox

Nitra

New York, US · Founded 2021 · 132 employees on LinkedIn · 35 known investors

Find your way into Nitra

650 people in our graph share verified history with the Nitra team — schools, employers, funds. One of them is your warm intro.

Tom Hulmeunlockedknows Tim Hwang · together at World Economic Forum (overlapped)
×7knows the team · via Square
knows the team · via World Economic Forum
knows the team · via Nitra
knows the team · via Plug and Play Ventures
knows the team · via Obama for America

Nitra provides a card, lending, and back-office platform built specifically for independent medical practices including ophthalmology, dental, aesthetics, and fertility clinics. The platform combines spending management, practice financing, bill pay, accounting, and AI-powered phone answering and claims verification.

Also known as Nitra Inc.

Founders & leadership

THTim Hwang
Tim HwanginChairman of the Board, Co-Founder and CEOVenture Scout at Prototype Capital

Investors · 35

Also in the syndicate · 10

AAFActions CapitalJerry Yang / AME Cloud VenturesK8New Enterprise AssociatesPIDC/Uni-PresidentPurestone SilksSazze PartnersSlope CapitalSparkLabs Taipei & Global

Funding

SEC filings, press & company announcements

$187M disclosed across 1 of 5 rounds · 2022–2026

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

Nitra is a New York-headquartered company that builds an all-in-one, AI-native operating platform for healthcare practices and their back offices. Its entry product is a Visa-powered business expense card designed for physicians, paired with spend management, business analytics and reconciliation software. Around that card the company has layered financial automation (bill pay, expense management, patient payment processing and AI agents for healthcare accounting), capital products (lending, equipment financing and insurance factoring), commerce and inventory tools, and patient-facing administration.

The commerce layer, marketed as NitraMart and Nitra Rx, gives practices direct access to tens of thousands of biopharmaceutical and medical equipment products through partnerships with distributors including McKesson and Medline, with AI procurement agents that handle supplier onboarding, price negotiation, purchasing and inventory monitoring. A patient management module launched in March 2026 uses voice AI agents, branded Trina, for phone answering in multiple languages, scheduling, benefits verification and insurance eligibility checks; the assistant also codes invoices, matches receipts and syncs with Nextech and QuickBooks. The platform is positioned to sit on top of a practice's existing bank accounts and EHR rather than replace them, with white-glove onboarding, and back-office modules such as BillPay, Accounting and Expenses offered at no additional software fee to Nitra Card customers.

Nitra targets specialties it describes as underserved by large banks, including ophthalmology, optometry and retina, plastic surgery, dermatology, med spa and injectables, dental specialty practices and IVF centers, as well as multi-site groups, MSOs and hospital-affiliated networks. The company cites SOC 2 Type II compliance, funds held at an FDIC-insured partner bank and operation on the Visa business network.

Founding story

Co-founders Tim Hwang and Jonathan Chen had previously worked together at legaltech company FiscalNote, which Hwang co-founded and took public before turning 30 after working on Barack Obama's 2008 presidential campaign and studying public policy at Princeton. Hwang traces the focus on healthcare to March 2020, when coverage of personal protective equipment shortages and intensive care unit overflows during COVID-19 highlighted structural weaknesses in the system; he and Chen decided their next company would be a long-term project in healthcare.

Business model

Nitra monetizes a land-and-expand model that begins with a healthcare-specific charge card and expands into lending, equipment financing, insurance factoring, a medical supplies and pharmaceutical marketplace, and AI-driven back-office and patient administration modules. Bill pay, accounting and expense tools are bundled free with the Nitra Card, without per-seat, per-transaction or subscription fees, while the card, capital products and marketplace commerce carry the economics. The company reported annualized revenue growing from about $4 million to over $33 million during 2025.

Revenue derives from card and payments volume, lending and financing products, and marketplace/procurement transactions rather than software subscriptions; the software layer is bundled with the card.

Traction

As of the March 2026 announcement, Nitra reported more than 700 clinics and thousands of doctors on the platform, 2,500+ healthcare professionals, over $1 billion in annualized processing volume, and over $33 million in annualized revenue as of December 2025 after roughly 740% (about eight-fold) growth during 2025. In December 2025 it supported upwards of $9 million in biopharma and medical purchases in a single day. Stated 2026 targets are more than 3,000 clinics, over $150 million in annualized revenue and over $4 billion in annualized processing volume, with headcount growing from 50 to more than 200.

Latest developments

On March 10, 2026, Nitra announced $187 million in financing spanning its Series A and Series B rounds, venture debt and an expanded warehouse facility, bringing total capital raised to $205 million and total equity raised to $90 million. Dr. Richard Park, founder and former CEO of CityMD, joined the board. The company launched its Patient Management module with voice AI agents in March 2026 and said it plans additional AI modules in revenue cycle management, patient marketing, and payroll/staffing. It also announced a Future of Care Initiative committing $20 billion in financing for independent medical practices.

Full profile — market position, technology, go-to-market, geography, history

Market position

Nitra positions itself as an AI-native operating system purpose-built for the business of medical practices, contrasting itself with generalist banks and with fragmented point solutions for payments, procurement, inventory, scheduling and insurance verification. It cites a U.S. healthcare market of nearly $5.9 trillion in which roughly 25% of spending goes to administrative costs.

Nitra combines spending, capital, back-office accounting and front-desk patient management in a single system built specifically for medical practices, rather than a card with add-on tools or separate logins. It sits on top of a practice's existing bank and EHR, bundles software with the card at no extra fee, and applies domain-specific AI agents to medical procurement, coding and insurance workflows.

Technology

The platform embeds AI agents into practice operations: procurement agents that source, negotiate and monitor inventory; accounting agents that code transactions and reconcile receipts; and voice AI agents (Trina) that answer calls in multiple languages, schedule patients and run insurance eligibility and benefits verification. It integrates with existing systems including Nextech and QuickBooks and operates over the Visa business network, with SOC 2 Type II certification and funds held at an FDIC-insured partner bank.

Go-to-market

Nitra enters practices through its physician-focused expense card, which management describes as a wedge or "Trojan horse," then expands into bill pay, accounting, procurement and agent-run administrative workflows. Sales are supported by white-glove onboarding, a partner/affiliate program for accountants, direct consultations with practice owners and office managers, and supplier and distributor partnerships.

Independent and multi-site medical practices in the United States, particularly eye care (ophthalmology, optometry, retina), aesthetics (plastic surgery, dermatology, med spa and injectors), dental specialty practices and IVF centers, plus MSOs and hospital-affiliated networks. Named customers include Bay Area Retina Associates, Southern Vitreoretinal Associates, Elase Medspa, PhyNet Dermatology, Brandywine Urology and Empower Aesthetics.

Geography

Headquartered in New York with a presence in San Francisco; customers are healthcare practices across the United States.

History

Nitra announced a $62 million seed raise in equity and debt in August 2022, launching a Visa business card and expense management software for physicians, with Jonathan Chen as founder and CEO and Tim Hwang as chair of the board while continuing at FiscalNote. The broader platform launched in 2024 under Tim Hwang as CEO and Jonathan Chen as president. A $22 million Series A closed in August 2025 and was disclosed alongside a $50 million Series B in March 2026, when the company also announced $20 million of venture debt, a $95 million warehouse facility, and the appointment of CityMD founder Dr. Richard Park to its board.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Annualized processing volumeMar 2026$1B
Annualized revenueDec 2025$33M
Clinics on platformMar 2026700 clinics
HeadcountJan 202550 employees
Healthcare professionals on platformJan 20262,500 professionals
Revenue growthJan 2025740%
Single-day biopharma and medical purchase volume supportedDec 2025$9M
Targeted annualized processing volumeJan 2026$4B
Targeted annualized revenueJan 2026$150M
Targeted clinicsJan 20263,000 clinics
Total capital raisedMar 2026$205M
Total equity raisedMar 2026$90M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Founder mafia

4 people who came through Nitra went on to found or lead other companies.

Timeline · 10

launches, deals, and filings
Mar 2026
$20 million venture debt facility from Avenue Capital Group

$20M source ↗

Mar 2026
Expanded $95 million warehouse facility from Treville Capital Group and Encina Lender Finance

$95M source ↗

Mar 2026
Nitra announces $187 million in financing across equity, venture debt and warehouse facility

The package comprised $72 million of new equity (a $50 million Series B and a previously unannounced $22 million Series A completed in August 2025), $20 million of venture debt from Avenue Capital Group, and an expanded $95 million warehouse facility from Treville Capital Group and Encina Lender Finance. Total capital raised reached $205 million and total equity raised $90 million.

$187M source ↗

Mar 2026
CityMD founder Dr. Richard Park joins board of directors

Dr. Richard Park, founder and former CEO of CityMD and co-founder and Managing Partner of Ascend Partners, joined Nitra's board of directors.

source ↗

Mar 2026
Commerce and inventory partnerships with McKesson and Medline

Nitra's commerce and inventory product provides direct access to tens of thousands of biopharmaceutical and medical equipment products in partnership with firms including McKesson and Medline.

source ↗

Mar 2026
Patient Management module with voice AI agents

Nitra launched Patient Management, using voice AI agents for patient scheduling, benefits verification, insurance eligibility checks and patient communication integrated into the operational stack.

source ↗

Jan 2026
Future of Care Initiative commits $20 billion in financing for independent practices

Nitra announced the Future of Care Initiative, a $20 billion financing commitment for independent medical practices across the United States.

$20B source ↗

Aug 2022
Nitra raises $62 million in seed equity and debt

Nitra announced $62 million in equity and debt capital from Andreessen Horowitz, NEA, Pantera Capital, KB Financial Group, Jerry Yang/AME Cloud Ventures and Will Smith's Dreamers VC, with CoVenture providing the debt facility.

$62M source ↗

Aug 2022
Supplier and vendor network partnerships

Nitra partnered with healthcare suppliers and vendors including Jaanuu, PatientPop, Betty Mills, DirectShifts, Vitality Medical, OhMD and LendingUSA.

source ↗

Aug 2022
Launch of Visa business card and expense management software for physicians

Nitra launched its first product, a no-annual-fee Visa Business card for healthcare practices with unlimited rewards on medical and surgical supplies, office spend and dining, supported by spend management, analytics and reconciliation software.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Nitra do?
AI-native operating platform giving independent medical practices cards, financing, procurement and back-office automation.
Who are Nitra's investors?
Nitra's investors include AAF Management Ltd., AppWorks Ventures, Dunamu & Partners, Expa, FoundersX Ventures, Gold House Ventures, Hyphen Capital, MARKHAM VALLEY VENTURES and 17 more.
How much funding has Nitra raised?
Nitra has disclosed $187M raised across 1 of its 5 known rounds.
Where is Nitra headquartered?
Nitra is headquartered in New York, US.